Search

Determining the structural origins of amyloid fibrillation is essential for understanding both the pathology of amyloidosis and the rational design of inhibitors to prevent or reverse amyloid formation. In this work, the decisive roles of peptide structures on amyloid self-assembly and morphological diversity were investigated by the design of eight amyloidogenic peptides derived from islet amyloid polypeptide. Among the segments, two distinct morphologies were highlighted in the form of twisted and planar (untwisted) ribbons with varied diameters, thicknesses, and lengths. In particular, transformation of amyloid fibrils from twisted ribbons into untwisted structures was triggered by substitution of the C-terminal serine with threonine, where the side chain methyl group was responsible for the distinct morphological change. This effect was confirmed following serine substitution with alanine and valine and was ascribed to the restriction of intersheet torsional strain through the increased hydrophobic interactions and hydrogen bonding. We also studied the variation of fibril morphology (i.e., association and helicity) and peptide aggregation propensity by increasing the hydrophobicity of the peptide side group, capping the N-terminus, and extending sequence length. We anticipate that our insights into sequence-dependent fibrillation and morphological diversity will shed light on the structural interpretation of amyloidogenesis and development of structure-specific imaging agents and aggregation inhibitors.

The diffusion of protons along biological surfaces and the interaction of biological structures with water are fundamental areas of interest in biology and chemistry. Here, we examine the surface of insulin amyloid fibrils and follow the binding of small molecules (photoacids) that differ according to the number and location of their sulfonic groups. We use transient fluorescence combined with a spherically-symmetric diffusion theory to show that the binding mode of different photoacids determines the efficiency of proton dissociation from the photoacid and the dimensionality of the proton's diffusion. We use molecular dynamics simulations to examine the binding mode and mechanism of the photoacids and its influence on the unique kinetic rates and diffusion properties of the photoacid's dissociated proton, where we also suggest a proton transfer process between one of the photoacids to proximal histidine residues. We show that the photoacids can be used as fluorescent markers for following the progression of amyloidogenic processes. The detailed characterisation of different binding modes to the surface of amyloid fibrils paves the way for better understanding of the binding mechanism of small molecules to amyloid fibrils.

There is an indispensable need for a fluorescence marker for the detection of amyloid fibrils, where, at present, the most used marker is thioflavin-T (ThT). Here, we present the use of auramine-O (AuO) as a possible alternative to ThT. As with ThT, the increase in the emission of AuO upon binding to amyloid fibrils is the result of inhibition of the free rotation of the two dimethylamino arms of the molecule. This inhibition prevents the excited-state electronic wave function from moving from the emissive locally excited state to the dark charge-transfer state. We further show that not only AuO is comparable to ThT as a fluorescent marker for amyloid fibrils but also it has a unique spectroscopic signature. AuO has distinct two modes that are characterized by a large shift in the absorption and emission peak positions between its unbound and bound states (before and after the fibrils formation, respectively). In this context, we show that, whereas the emission band position is red-shifting, the absorption peak shifts to the blue and the spectrum exhibits an isosbestic point. The large shifts in emission and absorption peak positions can be explained by the photoacid activity of AuO exhibiting an excited-state proton-transfer process.

Insulin, as other amyloid proteins, can form amyloid fibrils at certain conditions. The self-assembled aggregation process of insulin can result in a variety of conformations, starting from small oligomers, going through various types of protofibrils, and finishing with bundles of fibrils. One of the most common consensuses among the various self-assembly processes that are suggested in the literature is the formation of an early stage nucleus conformation. Here we present an additional insight for the self-assembly process of insulin. We show that at the early lag phase of the process (prior to fibril formation) the insulin monomers self-assemble into ordered nanostructures. The most notable feature of this early self-assembly process is the formation of nanocrystalline nucleus regions with a strongly bound electron-hole confinement, which also change the secondary structure of the protein. Each step in the self-assembly process is characterized by an optical spectroscopic signature, and possesses a narrow size distribution. By following the spectroscopic signature we can measure the potency of amyloid fibrils inhibitors already at the lag phase. We further demonstrate it by the use of epigallocatechin gallate, a known inhibitor for insulin fibrils. The findings can result in a spectroscopic-based application for the analysis of amyloid fibrils inhibitors., (Copyright © 2012 Elsevier Inc. All rights reserved.)

Thioflavin-T (ThT) can bind to amyloid fibrils and is frequentlyused as a fluo-rescent marker for in vitrobiomedicalassays of the potency of inhibitors for amyloid-related diseases,such as Alzheimer’s disease, Parkinson’s disease, andamyloidosis. Upon binding to amyloid fibrils, the steady-state (time-integrated)emission intensity of ThT increases by orders of magnitude. The simplicityof this type of measurement has made ThT a common fluorescent markerin biomedical research over the last 50 years. [ABSTRACT FROM AUTHOR]

Nanoscale bioimaging is a highly important scientific and technological tool, where fluorescent (FL) proteins, organic molecular dyes, inorganic quantum dots, and lately carbon dots are widely used as light emitting biolabels. In this work, a new class of visible FL bioorganic nanodots, self‐assembled from short peptides of different composition and origin, is introduced. It is shown that the electronic energy spectrum of native nonfluorescent peptide nanodots (PNDs) is deeply modified upon thermally mediated refolding of their biological secondary structure from native metastable to stable β‐sheet rich structure. This refolding leads to the appearance of a broadband optical absorption across visible region and tunable, excitation‐dependent visible FL of the nanodots with a high quantum yield of ≈30%. It is shown that this intriguing biophotonic effect appears in several peptides/proteins and does not require the presence of aromatic residues. It is assumed that the origin of the phenomenon is related to proton transfer along network of reconstructed intermolecular hydrogen bonds, stabilizing the thermally induced supramolecular β‐sheet structure. The biocompatible FL PNDs can be potentially applied as high‐resolution bioimaging labels toward advanced biotechnology and biomedical theranostics. A new class of fluorescent bioorganic nanodots self‐assembled from different short peptides is presented. The electronic energy spectrum of native non‐fluorescent nanodots is deeply modified upon thermally mediated refolding of their biological secondary structure from initial metastable to stable b‐sheet rich structure. This refolding leads to the tunable excitation dependent visible fluorescence of the nanodots. [ABSTRACT FROM AUTHOR]

Amyloid fibrillation is a nucleation-dependent process known be involved in the development of more than 20 progressive and chronic diseases. The detection of amyloid formation at the nucleation stage can greatly advance early diagnoses and treatment of diseases. In this work, we developed a new assay for the early detection of amylin fibrillation using the biarsenical dye 4,5-bis(1,3,2-dithiarsolan-2-yl)fluorescein (FlAsH), which could recognise tetracysteine motifs and transform from non-fluorescent form into strongly fluorescent complexes. Due to the close proximity of two cysteine residues within the hydrophilic domain of amylin, a non-contiguous tetracysteine motif can form upon amylin dimerisation or oligomerisation, which can be recognised by FlAsH and emit strong fluorescence. This enables us to report the nucleation-growth process of amylin without modification of the protein sequence. We showed that the use of this assay not only allowed the tracking of initial nucleation events, but also enabled imaging of amyloid fibrils and investigation of the effects of amyloid inhibitor/modulator toward amylin fibrillation. [ABSTRACT FROM AUTHOR]